We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
29 July 2022
Updated Application Materials for the 2023-2025 Funding Cycle
Application materials for the Global Fund’s 2023-2025 funding cycle are now available on our website, after going through extensive internal and external consultations and alignment with the new 2023-2028 Global Fund Strategy. -
25 July 2022
Promoting Gender Equality - Thematic Report
-
21 July 2022
John Grove appointed as the new Chief Evaluation and Learning Officer
The Global Fund is very pleased to announce the appointment of John Grove as its new Chief Evaluation and Learning Officer, starting on 1 October 2022. -
20 July 2022
Urgent C19RM Reinvestments
Due to the changing nature of the COVID-19 pandemic and contributing factors, the Global Fund will be supporting implementing countries to urgently reinvest COVID-19 Response Mechanism (C19RM) funds, where the initial intent of these investments no l... -
20 July 2022
2020-2022 Technical Review Panel Observations Report
The Global Fund is pleased to announce the release of the 2020-2022 Technical Review Panel Observations report. -
18 July 2022
Global Fund Appoints Susanne Kuehn as Ethics Officer and Head of the Ethics Office
The Global Fund is pleased to announce the appointment of Susanne Kuehn as the new Ethics Officer and Head of the Ethics Office. -
13 July 2022
Global Fund Ranks in Good Category in Leading Transparency Index
The Global Fund to Fight AIDS, Tuberculosis and Malaria has been included in the ‘Good’ category in a leading international aid transparency index published today. -
29 June 2022
Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP). -
29 June 2022
Opportunity for Evaluation of Pharmaceutical Products - Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial Medicines
The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP). -
21 June 2022
The Global Fund Joins Partners in Committing to Address Large Shortfalls in Oxygen